Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 3 | Unknown | PO / MO |
Patient missed last dose of Vivotif that was due on 11-Aug-2024; Case reference number US-BN-2024-002334 is a spontaneous case initially received from a consumer via agency (reference number: USBAV24-1932) on 11-Aug-2024 and concerns a male patient of unknown age. The patient's medical history and concomitant medication details were not provided. On unspecified dates, the patient took the first, second and third doses of Vivotif (batch numbers: unknown), one capsule, via oral use for unknown indication. As reported, the patient received three doses of Vivotif and the fourth dose of Vivotif was missed that was due which was left out of the refrigerator for 30 minutes to one hour, reached a maximum temperature of 95 degrees Fahrenheit (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Additional information received from a consumer via agency (reference number: USBAV24-1943) on 12-Aug-2024: included additional reference number (USBAV24-1943), additional reporter, gender of the patient and confirmation that last dose of Vivotif was not administred. Non-significant follow-up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240812-091580 to US-BAVARIAN NORDIC A/S-US-BN-2024-002334, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A male patient did not receive his fourth dose of Vivotif on time, which is considered Inappropriate schedule of vaccine administered. No associated adverse events were reported. Inappropriate schedule of vaccine administered is listed per company convention. Medical history or concomitant medications were not reported. Inappropriate schedule of vaccine administered is not related to Vivotif, but to a human error. The case is non-serious.; Sender's Comments: A male patient did not receive his fourth dose of Vivotif on time, which is considered Inappropriate schedule of vaccine administered. No associated adverse events were reported. Inappropriate schedule of vaccine administered is listed per company convention. Medical history or concomitant medications were not reported. Inappropriate schedule of vaccine administered is not related to Vivotif, but to a human error. The case is non-serious.
Comments: None.